Library staff can assist you with:
Contact or visit your local CLIN Library to find out more about our full range of services and for assistance with your research project.
Have you tried our new CLIN Libraries website - our improved one-stop shop to search across all the Libraries’ and CIAP’s online resources?
The official podcast of the Association of Diabetes Care & Education Specialists. Join us as we discuss the latest news in diabetes care, education, advocacy and technology.
Vol 208, Issue 10: 28 May 2018. Professor David Simmons is director of the Diabetes, Obesity and Metabolism Translational Research Unit at Western Sydney University. He discusses the treatment of booking GDM. With MJA news and online editor, Cate Swannell.
John Wilding gives an overview of the SURPASS findings to date, and discusses their importance and how tirzepatide may be used in the clinic.
The novel type 2 diabetes medication tirzepatide is a dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist. Its efficacy is being tested in the phase 3 SURPASS clinical trial program, with results of the cardiovascular outcomes study and a trial of tirzepatide in people with obesity but without diabetes expected in 2024. Explore this page for trial results and expert commentary, updated as new results are reported.
Medicine Matters diabetes is a resource for healthcare professionals caring for people with diabetes. Our objective is to provide information on the latest advances in diabetes medicine, to promote good clinical practice, and improve patient care.
Jean-Pierre Riveline uses data from real-life continuous glucose monitoring studies to illustrate how these can uncover critical information about clinical outcomes that are hard to assess in randomized controlled trials.
This video has been developed through unrestricted educational funding from Abbott Diabetes Care.
Join cardiologist Lars Rydén, endocrinologist Alice Cheng, and primary care practitioner Kevin Saunders who discuss the diagnosis and management of people with type 2 diabetes and shortness of breath in primary care, and how the positive findings of EMPEROR-Preserved will now shape the care of these patients.